Matched Unrelated Allogeneic Stem Cell Transplantation
Showing 9976 - 10000 of >10,000
Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (drug, other, procedure)
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- Ramucirumab
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Dec 21, 2022
EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)
Recruiting
- EGFR-Mutated Non-Small-Cell Lung Carcinoma
- Small Cell/Neuroendocrine
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Selective PET Imaging of Astrocytes and Microglia in Alzheimer's
Recruiting
- Alzheimer Disease
- Healthy
- Positron Emission Tomography (PET) using two PET tracer under IND
-
Houston, TexasHouston Methodist Research Institute
Jan 20, 2023
Small Cell Lung Carcinoma Trial in Barcelona, Madrid (Lurbinectedin, Pembrolizumab)
Recruiting
- Small Cell Lung Carcinoma
-
Barcelona, Spain
- +4 more
Aug 12, 2022
Non-Obstructive Coronary Atherosclerosis Trial in Guangzhou (Mental Stress Test)
Completed
- Non-Obstructive Coronary Atherosclerosis
- Mental Stress Test
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Dec 8, 2021
Blood Cell Response to Exercise
Withdrawn
- Metabolic Syndrome
- Moderate Physical Exercise
- (no location specified)
Jan 18, 2022
Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma Trial in United States (Sacituzumab Govitecan-hziy (SG))
Completed
- Gastric Adenocarcinoma
- +15 more
- Sacituzumab Govitecan-hziy (SG)
-
Aurora, Colorado
- +11 more
Aug 10, 2021
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Columbus
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Natural Killer Cell Therapy
- Temozolomide
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 28, 2022
Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Houston (procedure, drug,
Recruiting
- Invasive Breast Carcinoma
- +11 more
- Axillary Lymph Node Dissection
- +5 more
-
Houston, Texas
- +1 more
Mar 10, 2022
HIV/AIDS Trial in Guangzhou (Chidamide with CAR-T or TCR-T cell therapy)
Completed
- HIV/AIDS
- Chidamide with CAR-T or TCR-T cell therapy
-
Guangzhou, Guangdong, ChinaGuangzhou 8th People's Hospital
Jul 19, 2021
Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma Trial in Japan (ME-401)
Active, not recruiting
- Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma
-
Nagoya, Aichi, Japan
- +5 more
Dec 10, 2021
Antibiotic Resistant Strain Trial in Boston (Autologous fecal microbiota transplant (Auto-FMP Enema), Placebo Enema Preparation)
Completed
- Antibiotic Resistant Strain
- Autologous fecal microbiota transplant (Auto-FMP Enema)
- Placebo Enema Preparation
-
Boston, MassachusettsBoston University - Boston Medical Center nursing home consortiu
Apr 13, 2021
Obesity, Fasting, T-Cell Dysfunction Trial (Fasting)
Not yet recruiting
- Obesity
- +2 more
- Fasting
- (no location specified)
May 23, 2023
High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements, High Grade B-Cell Lymphoma, Not Otherwise Specified,
Recruiting
- High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements
- +4 more
- Orelabrutinib+R-CHOP; Orelabrutinib+R-DA-EPOCH; Orelabrutinib+R-HD MTX;Orelabrutinib+R+other chemotherapies
-
Jinan, Shandong, ChinaShandong Provincial Hospital
Nov 18, 2021
Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +20 more
- Neoantigen Peptide Vaccine
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 7, 2022
Following Hand-Assisted And Robotic Living Donor Nephrectomy: A
Recruiting
- Transplant
- Kidney Diseases
- kidney transplant
-
Dallas, TexasThe Liver Institute at Methodist Dallas Medical Center
Dec 9, 2021
Lymphoma, Lymphoma, Mantle-Cell, Tumors by Histologic Type Trial (IM19 CAR-T cells, Cyclophosphamide, Fludarabine)
Not yet recruiting
- Lymphoma
- +4 more
- IM19 CAR-T cells
- +2 more
- (no location specified)
Nov 30, 2021
Hepatocellular Carcinoma Trial in Belgium (Liver transplantation)
Recruiting
- Hepatocellular Carcinoma
- Liver transplantation
-
Antwerpen, Belgium
- +5 more
Aug 27, 2022
Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in
Recruiting
- Autoimmune Hemolytic Anemia
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 9, 2022
Antifibrinolytic Agents Trial in Berne (Tranexamic acid bolus 20 mg/kg, Tranexamic acid bolus 10 mg/kg, Tranexamic acid bolus 1
Not yet recruiting
- Antifibrinolytic Agents
- Tranexamic acid bolus 20 mg/kg
- +3 more
-
Berne, SwitzerlandDpt. Anesthesiology and pain Medicine
Nov 13, 2023
B Cell Non-Hodgkin's Lymphoma Trial in Beijing (CD19/CD20-directed Chimeric Antigen Receptor T Cells)
Recruiting
- B Cell Non-Hodgkin's Lymphoma
- CD19/CD20-directed Chimeric Antigen Receptor T Cells
-
Beijing, ChinaPeking University Cancer Hospital
Nov 24, 2021
Small Cell Lung Cancer Trial in Fuzhou (Surufatinib,Serplulimab,Etoposide,Carboplatin)
Not yet recruiting
- Small Cell Lung Cancer
-
Fuzhou, Fujian, ChinaFujian Cancer Hospital
May 20, 2023
Influenza, Human, Influenza in Birds, Respiratory Tract Infections Trial in United States (aH5N6c on Day 1, aH5N6c on Day 22,
Recruiting
- Influenza, Human
- +7 more
- aH5N6c on Day 1
- +2 more
-
Huntsville, Alabama
- +17 more
Jul 26, 2022